ArticleEpidemiology and infection2008
Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005.
Article in Epidemiology and infection, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.
- Vaccination in England: a review of why business as usual is not enough to maintain coverage.BMC public health · 2018Pooled it
- Interventions to reduce inequalities in vaccine uptake in children and adolescents aged <19 years: a systematic review.Journal of epidemiology and community health · 2017Pooled it
- Adherence to Advisory Committee on Immunization Practices in diabetes mellitus patients in Saudi Arabia: A multicenter retrospective study.World journal of diabetes · 2024Article
- COVID-19 vaccination uptake amongst ethnic minority communities in England: a linked study exploring the drivers of differential vaccination rates.Journal of public health (Oxford, England) · 2023Article
- Association between health and safety perceptions of COVID-19 vaccine and its uptake in Ghana.Public health challenges · 2022Article
- Cost-effectiveness and budget impact analysis of PPV23 vaccination for the Malaysian Hajj pilgrims.PloS one · 2022Article
- Sociodemographic inequality in COVID-19 vaccination coverage among elderly adults in England: a national linked data study.BMJ open · 2021Article
- A quality improvement intervention failed to significantly increase pneumococcal and influenza vaccination rates in immunosuppressed inflammatory arthritis patients.Clinical rheumatology · 2020Article
- Vaccinations against respiratory infections in Arabian Gulf countries: Barriers and motivators.World journal of clinical cases · 2017Article
- Determinants of influenza vaccination among solid organ transplant recipients attending Sicilian reference center.Human vaccines & immunotherapeutics · 2017Observational
- Ethnicity, deprivation and mortality due to 2009 pandemic influenza A(H1N1) in England during the 2009/2010 pandemic and the first post-pandemic season.Epidemiology and infection · 2015Article
- Ethnic variations in morbidity and mortality from lower respiratory tract infections: a retrospective cohort study.Journal of the Royal Society of Medicine · 2015Article
- Vaccination of adolescents with chronic medical conditions: Special considerations and strategies for enhancing uptake.Human vaccines & immunotherapeutics · 2015Review
- Adult immunization policies in advanced economies: vaccination recommendations, financing, and vaccination coverage.International journal of public health · 2013Article
- Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based study.BMC infectious diseases · 2013Article
- Is it worth investigating splenic function in patients with celiac disease?World journal of gastroenterology · 2013Review
- Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.Emerging infectious diseases · 2013Article
- Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010.Emerging infectious diseases · 2011Article
- Routinely measuring and reporting pneumococcal vaccination among immunosuppressed rheumatology outpatients: the first step in improving quality.Rheumatology (Oxford, England) · 2011Article
- Identification of new risk factors for pneumonia: population-based case-control study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The UK has had a pneumococcal polysaccharide vaccination (PPV) programme for groups at higher risk of invasive disease since 1992. This paper presents data from a sample of primary-care practices (Q-RESEARCH) of PPV uptake in patients according to their risk status. Of 2.9 million registered patients in 2005, 2.1% were vaccinated with PPV in the preceding 12 months and 6.5% in the preceding 5 years. Twenty-nine per cent of the registered population fell into one or more risk groups. The proportion of each risk group vaccinated in the previous 5 years ranged from 69% (cochlear implants), 53.4% (splenic dysfunction), 36.5% (chronic heart disease), 34.7% (diabetes), 22.9% (immunosuppressed), 28.7% (chronic renal disease), 15.9% (sickle cell disease) to 12.6% (chronic respiratory disease). Uptake was lower in areas where the non-white proportion of population was >10%. In conclusion, there remain large gaps in the uptake of PPV in several high-risk populations in the United Kingdom. Effective strategies need to be developed to address these deficiencies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.